Other languages CytoDyn Inc.

Equities

CYDY

US23283M1018

Market Closed - OTC Markets Other stock markets 03:59:57 2024-04-23 pm EDT			5-day change	1st Jan Change
0.15 ^USD	-0.07%		+1.35%	-23.08%

Apr. 15	CytoDyn Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended February 29, 2024	CI
Mar. 05	Transcript : CytoDyn Inc. - Special Call

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

CytoDyn Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended February 29, 2024	Apr. 15
CytoDyn Inc. Announces Submission of Clinical Protocol to FDA and Initiation of Pre-Clinical Study in Glioblastoma	Feb. 01
CytoDyn Inc. Announces Appointment of Jacob Lalezari as CEO	Jan. 29
CytoDyn Inc. Reports Earnings Results for the Second Quarter and Six Months Ended November 30, 2023	Jan. 16
CytoDyn Inc. Appoints Jacob Lalezari M.D. as Interim CEO	Nov. 21
CytoDyn Inc. Reports Earnings Results for the First Quarter Ended August 31, 2023	23-10-23
CytoDyn Inc. Reports Earnings Results for the Full Year Ended May 31, 2023	23-09-14
CytoDyn Inc. Announces CEO Changes	23-07-11
CytoDyn Inc. Announces Executive Changes	23-07-11
CytoDyn Inc. Announces Executive Changes	23-05-24
CytoDyn Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended February 28, 2023	23-04-10
CytoDyn Inc. Reports Earnings Results for the Second Quarter and Six Months Ended November 30, 2022	23-01-09
4 minutos de mercados del viernes 23 de diciembre	22-12-23
4 minutos de mercados del jueves 22 de diciembre	22-12-22
4 minutos de mercados del miércoles 21 de diciembre	22-12-21
CYTODYN : l’ancien PDG de la biotech inculpé pour déclarations frauduleuses	22-12-21
Uniper sauvé, Engie raboté, virage pour 3M, déception pour General Mills : Planète Bourse du mercredi 21 décembre	22-12-21
CytoDyn Inc. Announces Resignation of Scott A. Kelly, Chief Medical Officer	22-12-19
Nitya G. Ray Resigns as Chief Technology Officer of CytoDyn Inc	22-11-25
CytoDyn Announces Voluntary Withdrawal of BLA for HIV-MDR Due to CRO Data Management Issues	22-10-28

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages CytoDyn Inc.

Equities

CYDY

US23283M1018

Other languages

Filters